Resultados de la búsqueda 1-10 of 1404 for ���������������������������op������r���:za33���

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international ... (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study to Collect Clinical ...

  5. Untitled

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) chronic lymphocytic leukemia (CLL). MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...